- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of influenza
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 538KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 85KB)
Influenza Vaccine – March 2024
Influenza Vaccine: Injection 0.5 mL; Flucelvax® Quad
Last updated
30 May 2025